Using vaccine data combined with electronic health records, we report that mRNA boosters provide greater protection than a 2-dose regimen against SARS-CoV-2 infection and related hospitalizations. The benefit of a booster was more evident in the elderly and those with comorbidities.
|Original language||English (US)|
|Number of pages||3|
|Journal||Clinical infectious diseases : an official publication of the Infectious Diseases Society of America|
|State||Published - Sep 14 2022|
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases